• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)
Date Designated:  01/08/2018
Orphan Designation:  Treatment of glioblastoma multiforme
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
AXIUM Pharmaceuticals, Inc.
265 Eastchester Drive
Suite 133, #201
High Point, North Carolina 27262
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-